Free Trial
→ Trump Treasure April 19 (From Paradigm Press) (Ad) Buy CTXR Stock  Free CTXR Stock Alerts

Citius Pharmaceuticals (CTXR) SEC Filings & 10K Form

Citius Pharmaceuticals logo
$1.03 -0.15 (-12.71%)
Closing price 04:00 PM Eastern
Extended Trading
$1.06 +0.03 (+3.40%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Citius Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/02/2025
6:27 AM		Citius Pharmaceuticals (Filer)
Form 424B5
03/10/2025
3:30 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:30 PM		Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/06/2025
8:20 AM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:05 PM		Citius Pharmaceuticals (Filer)
Form DEF 14A
01/27/2025
3:07 PM		Citius Pharmaceuticals (Filer)
Form DEFA14A
01/16/2025
3:30 PM		Citius Pharmaceuticals (Filer)
Form PRE 14A
01/08/2025
3:05 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
8:00 AM		Citius Pharmaceuticals (Filer)
Form 424B5
01/07/2025
8:11 AM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:10 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:00 PM		Citius Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/20/2024
3:30 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:05 PM		Citius Pharmaceuticals (Subject)
Mazur Leonard L (Filed by)
Form SC 13D/A
11/25/2024
4:15 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:15 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:30 AM		Citius Pharmaceuticals (Filer)
Form 424B5
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Smith Robert Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:00 PM		Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
4:25 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:26 PM		Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
4:27 PM		Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
7:30 AM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
4:26 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:15 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:01 PM		Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:01 PM		Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:34 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Pharmaceuticals (Filed by)
Form SC 13D
08/16/2024
3:35 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
5:19 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:25 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:10 PM		Citius Pharmaceuticals (Filer)
Form 424B5
08/12/2024
4:25 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:51 PM		Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
08/08/2024
8:20 AM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:05 PM		Citius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
1:22 PM		BlackRock Inc. (Filed by)
Citius Pharmaceuticals (Subject)
Form SC 13G/A
04/30/2024
3:21 PM		Citius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CTXR) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...
Porter & Company | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...
InvestorPlace | Sponsored
New “Trump” currency proposed in DC
After a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...
Paradigm Press | Sponsored
DOGE Social Security bombshell?
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Trump’s Secret Weapon
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
Trump Makes Major Crypto Announcement
Trump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...
Crypto 101 Media | Sponsored